Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A McCaffrey

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Clinical Colorectal Cancer|October 14, 2009
Trichomegaly of the eyelashes after colorectal cancer treatment with the epidermal growth factor receptor inhibitor cetuximabRichard Bambury, J A McCaffrey
The Journal of Urology|June 17, 1998
Interstitial pneumonitis following bicalutamide treatment for prostate cancerJ A McCaffrey, H I Scher
Surgical Oncology Clinics of North America|October 6, 1997
Adjuvant and neoadjuvant chemotherapy for urothelial carcinomaJ A McCaffrey, H W Herr
The Cancer Journal From Scientific American|July 1, 1997
'Casodex': defining the role of antiandrogensJ A McCaffrey, H I Scher
Seminars in Oncology|April 30, 1998
Therapy for good risk germ cell tumorsJ A McCaffrey, D F Bajorin
Irish Journal of Medical Science|November 1, 2006
Collecting duct carcinoma of the kidney: a case report with variable immunohistochemistryR M Connolly, P Downey, J A McCaffrey
The Urologic Clinics of North America|September 5, 1998
Risk assessment for metastatic testis cancerJ A McCaffrey, D F Bajorin, R J Motzer
Cancer|October 1, 1977
The relative roles of gallium-67-citrate scanning and lymphangiography in the current management of malignant lymphomaR A Rudders, J A McCaffrey, P C Kahn
Irish Journal of Medical Science|March 2, 2005
High dose chemotherapy and stem cell support for poor risk and recurrent nonseminomatous germ cell cancer: initial experience with sequential therapyB Hennessy, J A McCaffrey, P Daly, et al.
Oncology (Williston Park, N.Y.)|October 23, 1997
Combined-modality therapy for bladder cancerJ A McCaffrey, D F Bajorin, H I Scher, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Clinical Colorectal Cancer|October 14, 2009
Trichomegaly of the eyelashes after colorectal cancer treatment with the epidermal growth factor receptor inhibitor cetuximabRichard Bambury, J A McCaffrey
The Journal of Urology|June 17, 1998
Interstitial pneumonitis following bicalutamide treatment for prostate cancerJ A McCaffrey, H I Scher
Surgical Oncology Clinics of North America|October 6, 1997
Adjuvant and neoadjuvant chemotherapy for urothelial carcinomaJ A McCaffrey, H W Herr
The Cancer Journal From Scientific American|July 1, 1997
'Casodex': defining the role of antiandrogensJ A McCaffrey, H I Scher
Seminars in Oncology|April 30, 1998
Therapy for good risk germ cell tumorsJ A McCaffrey, D F Bajorin
Irish Journal of Medical Science|November 1, 2006
Collecting duct carcinoma of the kidney: a case report with variable immunohistochemistryR M Connolly, P Downey, J A McCaffrey
The Urologic Clinics of North America|September 5, 1998
Risk assessment for metastatic testis cancerJ A McCaffrey, D F Bajorin, R J Motzer
Cancer|October 1, 1977
The relative roles of gallium-67-citrate scanning and lymphangiography in the current management of malignant lymphomaR A Rudders, J A McCaffrey, P C Kahn
Irish Journal of Medical Science|March 2, 2005
High dose chemotherapy and stem cell support for poor risk and recurrent nonseminomatous germ cell cancer: initial experience with sequential therapyB Hennessy, J A McCaffrey, P Daly, et al.
Oncology (Williston Park, N.Y.)|October 23, 1997
Combined-modality therapy for bladder cancerJ A McCaffrey, D F Bajorin, H I Scher, et al.
Pageof 3